NCT04285905 (mPATCH-TB) is a Phase 2, PHASE3 clinical trial of Access to Fast Track TB clinic in Tuberculosis, sponsored by Liverpool School of Tropical Medicine.

Who is sponsoring NCT04285905?

NCT04285905 is sponsored by Liverpool School of Tropical Medicine.

What drugs are being tested in NCT04285905?

Interventions in NCT04285905: Access to Fast Track TB clinic, Information leaflet for male partner, Home sputum collection, Home HIV testing, Financial incentive.

What condition does NCT04285905 study?

NCT04285905 studies Tuberculosis.

Is NCT04285905 still recruiting?

NCT04285905 is currently terminated. Last updated 25 February 2021.

Last reviewed 2021-02-25 · How we verify

NCT04285905: mPATCH-TB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi

Terminated Phase 2, PHASE3 Last updated 25 February 2021

What this trial tests

Phase 2, PHASE3 trial testing Access to Fast Track TB clinic in Tuberculosis in 30 participants. Terminated before completion.

Timeline

10 April 2019

Primary endpoint
28 March 2020

28 March 2020

Quick facts

Lead sponsor	Liverpool School of Tropical Medicine
Phase	Phase 2, PHASE3
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	30
Start date	10 April 2019
Primary completion	28 March 2020
Estimated completion	28 March 2020
Sites	1 location across Malawi

Drugs / interventions tested

Access to Fast Track TB clinic
Information leaflet for male partner
Home sputum collection
Home HIV testing
Financial incentive

Conditions studied

Tuberculosis — all drugs for Tuberculosis →

Sponsor

Liverpool School of Tropical Medicine

Who can join

18 and older, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of the mPATCH-TB Study is to identify potentially cost-effective, feasible and scalable interventions that could increase rates of completion of screening for tuberculosis and HIV among male partners of women attending primary health care in Blantyre, Malawi. Eligible women who consent to participate - and who have a primary male partner with cough at home -will be randomly allocated, by day of clinic attendance, into a standard of care group or one of up to four intervention groups. They will be asked to identify their primary male partner and will be offered interventions according to their allocated group. The primary outcome will compare the proportion of primary male partner that complete TB screening (defined as receipt of result of a sputum Xpert or smear result) within 14 days of recruitment in each intervention group compared to the enhanced standard of care group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting

Other Liverpool School of Tropical Medicine trials

Trials by the same sponsor.

NCT07403318 — Mobile Health Supported Self-care Among Tertiary Education Students in Zimbabwe · NA · not yet recruiting
NCT06944275 — Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome · not yet recruiting
NCT07504926 — A Randomised Feasibility Study of CPAP in Large Airway Collapse · NA · not yet recruiting
NCT07248423 — Start Taking Action for Tuberculosis in Kids · NA · not yet recruiting
NCT07420881 — Start4All - Start Taking Action for TB Diagnosis (DARE-TB) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04285905 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Liverpool School of Tropical Medicine
Last refreshed: 25 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04285905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing